stockportfolio.pro
Vertex Pharmaceuticals Incorporated Revenue 2008–2025
Vertex Pharmaceuticals Incorporated (VRTX) annual revenue by fiscal year, computed from SEC filings. Compound growth +28.2%/yr over 17 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $12.00B | +8.9% |
| FY 2024 | $11.02B | +11.7% |
| FY 2023 | $9.87B | +10.5% |
| FY 2022 | $8.93B | +17.9% |
| FY 2021 | $7.57B | +22.1% |
| FY 2020 | $6.21B | +49.1% |
| FY 2019 | $4.16B | +36.6% |
| FY 2018 | $3.05B | +22.5% |
| FY 2017 | $2.49B | +46.2% |
| FY 2016 | $1.70B | +64.9% |
| FY 2015 | $1.03B | +77.9% |
| FY 2014 | $580.41M | -52.1% |
| FY 2013 | $1.21B | -20.6% |
| FY 2012 | $1.53B | +8.3% |
| FY 2011 | $1.41B | +883.9% |
| FY 2010 | $143.37M | +40.7% |
| FY 2009 | $101.89M | -41.9% |
| FY 2008 | $175.50M | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's revenue?
Vertex Pharmaceuticals Incorporated (VRTX) reported revenue of $12.00B for fiscal year 2025, per its SEC filings.
How has Vertex Pharmaceuticals Incorporated's revenue changed over time?
Between fiscal 2008 and 2025, VRTX's revenue grew at roughly 28.2% per year (compound annual rate), from $175.50M to $12.00B.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.